The REAL Reason Dementia is SKYROCKETING
The REAL Reason Dementia Is SKYROCKETING
Video/source: Neal K. Shah interview with Dr. Dale Bredesen
Participants: Neal K. Shah and neurologist/researcher Dr. Dale Bredesen
Publication date: August 30, 2026 according to the indexed video summary; another indexed page gives August 29, so we use the date displayed on YouTube itself as authoritative before publishing. Third-Party Re-Publication September 23, 2026
Dr. Dale Bredesen says everything we’ve been told about dementia and Alzheimer’s is WRONG. What if the plaques in your brain aren’t attacking you… but trying to protect you? He spent 30 years running a lab and a decade running an aging institute, and now he shares his ideas with the world.
I’ve worked to help dementia caregivers for years – and I’ve watched people slip away to this disease. The hardest part isn’t just the disease itself, but the silence around it, and the feeling that nothing could be done. Dr. Dale Bredesen has spent his career arguing that it’s not hopeless and there is something we can do to help people.
Dr. Bredesen – neurologist, New York Times bestselling author of “The End of Alzheimer’s,” and founding President of the Buck Institute for Research on Aging – walks through the paradigm shift happening in neurology now: amyloid and tau may be your brain’s protective response to something upstream, not the disease itself. Both are antimicrobial. Your body makes them for a reason. If you never find the reason, removing them doesn’t restore memory.
He breaks down the three drivers he says push the brain from “connection mode” into “protection mode”: reduced energetics (blood flow, sleep apnea, mitochondria), chronic inflammation (leaky gut, sinusitis, the oral microbiome, metabolic syndrome), and toxins (metals, air pollution, microplastics, mold biotoxins). Plus three he calls intermediate — neurotransmitters, trophic support, and chronic unremitting stress.
Alzheimer’s has four stages, and the pathology can begin 20 years before diagnosis. Stage two — subjective cognitive impairment, when you know something’s off but still test normal — lasts about a decade on average. That’s the window. He explains what to test, when to start (he says 35), and the three changes he’d make first if you’re a caregiver with no time and no bandwidth.
We also cover the most under-tested condition in America, whether crossword puzzles actually help, the red wine question I get from stressed-out caregivers constantly, and the psilocybin case report everyone keeps sending me.
CHAPTERS
00:00 Why I wanted this conversation
01:22 An attack on the brain, or a defense?
02:56 The 3 major drivers: energetics, inflammation, toxins
04:28 The 3 intermediate drivers, including chronic stress
05:40 Amyloid, tau, and the herpes connection
07:26 Why Alzheimer’s drugs keep failing
09:55 Connection mode vs. protection mode explained
11:53 The 10-year window for prevention
12:54 “I was taught nothing can be done”
14:23 Inside the randomized trial
14:55 The 4 stages of Alzheimer’s, defined
16:59 Why it starts 20 years before diagnosis
17:39 SCI: the reversible stage almost nobody catches
18:50 The $100,000 cost, and the p-tau217 test
20:42 Why “mild cognitive impairment” misleads
21:08 Outcomes at each stage
26:01 The 7 basics of the protocol
26:58 The 4 sleep numbers he checks daily
29:29 What supplements can and can’t do
30:36 Your mouth and your brain: oral DNA testing
32:04 Why the practitioner matters most
35:26 Test before you intervene
36:00 If you only fix 3 things: #1 is your metabolism
40:00 #2 exercise, plus exercise with oxygen therapy (EWOT)
41:46 #3 sleep, and the 80% who don’t know
42:50 Psilocybin: what the case report showed
47:00 Rapid fire: do crosswords and Sudoku actually work?
48:22 One glass of red wine a night: help or harm?
50:00 Just diagnosed? What he tells people
50:06 The one thing he’d delete from the modern diet
51:21 What he’d change about Alzheimer’s care
53:13 Where to find “The Ageless Brain”
QUESTIONS ANSWERED: Can Alzheimer’s be prevented or reversed? What causes Alzheimer’s besides genetics? What are the four stages? What is subjective cognitive impairment? How early does Alzheimer’s start? What blood test detects Alzheimer’s risk? Does gum disease cause dementia? Does sleep apnea increase dementia risk? Do brain games work? ABOUT Neal K. Shah is a Johns Hopkins- and NIH-funded caregiving researcher and CEO of CareYaya, and has helped thousands of families navigate aging, dementia, and serious illness. This channel breaks down the health and caregiving news that actually affects older adults and the people who care for them.
GUEST: Dr. Dale Bredesen, author of “The Ageless Brain,” “The End of Alzheimer’s,” “The End of Alzheimer’s Program,” and “The First Survivors of Alzheimer’s.”
Educational only, not medical advice. It reflects Dr. Bredesen’s clinical views and research; the randomized trial discussed is a preprint that has not completed peer review. Talk with your physician before changing diet, supplements, medications, or care. If this reframed how you think about brain health, please share it with someone who needs it.
Subscribe for more on aging, dementia, and caregiving. #Alzheimers#Dementia#BrainHealth#DaleBredesen#Aging
How this was made
Auto-dubbed
Audio tracks for some languages were automatically generated. Learn more
Ask
Get answers, explore topics, and more
Ask questions
ChaptersView all
Webpage Summary
Neurologist and Alzheimer’s researcher Dr. Dale Bredesen joins Neal K. Shah for an extended discussion of Alzheimer’s disease, dementia, cognitive decline, and approaches intended to preserve brain health.
Bredesen presents Alzheimer’s disease as a complex process involving multiple biological systems rather than a disorder attributable to a single cause. He discusses reduced energy supply to the brain, inflammation, metabolic dysfunction, chronic infections, environmental exposures, sleep apnea, stress, nutritional factors, and loss of neuroplasticity as potential contributors that he believes should be evaluated when addressing cognitive decline.
A central theme is Bredesen’s distinction between treating downstream features of Alzheimer’s disease—such as amyloid and tau—and identifying factors that may be contributing to the disease process. He describes his view that amyloid and phosphorylated tau can participate in protective responses and argues for a systems-oriented approach to understanding neurodegeneration.
The interview examines the progression from presymptomatic disease through subjective cognitive impairment (SCI), mild cognitive impairment (MCI), and dementia. Bredesen emphasizes early identification and intervention, discussing emerging biomarkers such as p-tau217 as well as cognitive testing and brain imaging.
Bredesen also describes the ReCODE approach and a broad group of interventions involving nutrition, exercise, sleep, stress management, brain training, metabolic health, and individualized evaluation of potential infections and environmental exposures. He discusses clinical trials of this precision-medicine approach and reports improvements among many participants with mild cognitive impairment or early dementia.
Other topics include the oral microbiome, sleep apnea, ApoE4, exercise and oxygenation, photobiomodulation, ketogenic diets, ultra-processed foods, toxins and mycotoxins, supplements, and the emerging scientific interest in psychedelics and neuroplasticity.
Throughout the conversation, Bredesen emphasizes prevention and earlier recognition of cognitive changes. He argues that maintaining brain health should become a lifelong objective rather than something addressed only after significant cognitive impairment has developed.
The interview presents Bredesen’s interpretation of Alzheimer’s disease research and his clinical approach. Several of the mechanisms, tests and treatments discussed remain subjects of active scientific investigation and should not be interpreted as individualized medical advice.
“We have to go from what it is to why it is.” — Dr. Dale Bredesen, ~2:36–2:45
“The earlier you intervene, the better chance you have for success.” — ~14:18
“90% of the people showed improvement who were in the treatment arm compared to the standard of care.” — ~14:27–14:40
“Treating blindly is not a particularly good idea.” — ~35:20–35:26
Transcript
Follow along using the transcript.
Show transcript
Instagram – Neal K. Shah
Facebook – Neal K. Shah
LinkedIn – Neal K. Shah
TikTok – Neal K. Shah
Educational Disclaimer: informational purposes only
Not medical, legal, or professional advice
AI Assistance Disclosure:
This content was created with the assistance of AI tools for summarization, structuring, and formatting. All editorial selection, interpretation, and final publication decisions are made by the publisher. AI is used only as an assistive tool and does not replace human editorial oversight or responsibility.
Third-Party Re-Publication Notice:
This article is republished by USA Citizens Network for informational and public discussion purposes. The original content, authorship, and opinions belong to the original source.
Source Usage Notice:
This content may include quotations or referenced materials used for educational discussion.
